No title
Tuberculosis and nontuberculous mycobacterial infections remain a major global health challenge due to rising antimicrobial resistance, prolonged treatment regimens, and the complex, poorly permeable structure of the mycobacterial cell envelope. This envelope limits antibiotic penetration and contributes to intrinsic drug tolerance. Bacteriophage-derived lytic enzymes, including Lysin A (LysA) and
